AFP and hepatocellular carcinoma: It was valuable that SHh was above the upper limit in nearly 70% of AFP-negative patients, and by combining both AFP and SHh assays, the positive rate was increased to 85.7%, indicating that SHh has a compensating role for diagnosis of HCC in AFP-negative patients.